TC
CVAC

TwinBeech Capital’s CureVac CVAC Stock Holding History

TwinBeech Capital’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-68,548
Closed -$413K – 668
2022
Q4 		$413K Buy
68,548
+22,188
+48% +$164K 0.01% 608
2022
Q3 		$365K Buy
+46,360
New +$541K 0.01% 550
2022
Q2 		– Sell
-82,547
Closed -$1.62M – 543
2022
Q1 		$1.62M Buy
82,547
+15,043
+22% +$300K 0.07% 264
2021
Q4 		$2.32M Buy
+67,504
New +$2.72M 0.13% 207
2021
Q3 		– Sell
-9,444
Closed -$694K – 616
2021
Q2 		$694K Buy
+9,444
New +$944K 0.08% 264

Other funds holding CVAC

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

TwinBeech Capital's CVAC Position: Q1 2023 in Review

TwinBeech Capital sold out of CureVac (CVAC) in Q1 2023, closing a stake of 68,548 shares — an estimated $413K sold.

TwinBeech Capital first reported a position in CVAC in Q2 2021 and held it in 5 quarters. The position peaked at $2.32M in Q4 2021. 82 funds tracked by Wall St. Rank hold CVAC as of Q1 2023.

  • TwinBeech Capital reported no remaining CureVac position as of Q1 2023 after selling out during the quarter.
  • TwinBeech Capital sold 68,548 CureVac shares in Q1 2023, an estimated $413K.
  • TwinBeech Capital first reported a position in CureVac in Q2 2021 and held it in 5 quarters.
  • TwinBeech Capital's CureVac position peaked at $2.32M in Q4 2021.
  • 82 funds tracked by Wall St. Rank held CureVac as of Q1 2023.

Based on TwinBeech Capital's 13F filing for Q1 2023, filed 15 May 2023.